Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study
European Urology Focus · 2023
DOI: 10.1016/j.euf.2023.01.016 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Urology Focus, 2023. Verfasst von Fabio Zattoni und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department Surgery, Oncology and Gastroenterology, Urologic Unit, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Urology, Prostatic Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Padua.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: The concordance rates of transperineal (TP) versus transrectal (TR) prostate biopsies with radical prostatectomy (RP) specimen have been assessed poorly in men diagnosed with magnetic resonance imaging (MRI)-targeted biopsy (TBx). OBJECTIVE: To evaluate International Society of Urological Pathology (ISUP) concordance rates between the final pathology at RP and MRI-TBx or MRI-TBx + random biopsy (RB) according to the biopsy approach. DESIGN, SETTING, AND PARTICIPANTS: A multi-institutional database included patients diagnosed with TP or TR treated with RP. INTERVENTION: TP-TBx or TR-TBx of the prostate. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The ISUP grade at biopsy was compared with the final pathology. A multivariable logistic regression analysis (MVA) was performed to assess the association between the biopsy approach (TP-TBx vs TR-TBx) and ISUP upgrading, downgrading, concordance, and clinically relevant increase (CRI). RESULTS AND LIMITATIONS: Overall, 752 (59%) versus 530 (41%) patients underwent TR versus TP. At the MVA, TP-TBx was an independent predictor of upgrading (odds ratio [OR] 0.6, 95% confidence interval [CI] 0.4-0.9, p < 0.01) and improved concordance relative to the final pathology (OR 1.7, 95% CI 1.2-2.5, p < 0.01) after adjusting for age, cT stage, Prostate Imaging Reporting and Data System, number of targeted cores, prostate-specific antigen, and prostate volume. Moreover, TP-TBx was associated with a lower risk of CRI than TR-TBx (OR 0.7, p < 0.01). This held true when considering patients who underwent MRI-TBx + RB (OR 0.6, p < 0.01). The inclusion of men who had RP represents a potential selection bias. CONCLUSIONS: The adoption of TP-TBx compared with TR-TBx may reduce the risk of upgrading and improve the concordance of biopsy grade with the final pathology. The TP approach decreases the odds of CRI with improved patient selection for the correct active treatment. PATIENT SUMMARY: In this report, we evaluated whether transperineal (TP) targeted biopsy (TBx) may improve the concordance of clinically significant prostate cancer with the final pathology in comparison with transrectal (TR) TBx in a large worldwide population. We found that TP-TBx might increase concordance compared with TR-TBx. Adding random biopsies to target one increases accuracy; however, concordance with the final pathology is overall suboptimal even with the TP approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department Surgery, Oncology and Gastroenterology, Urologic Unit, University of Padova, Padova, Italy.
- Department of Urology, Institut Mutualiste Montsouris, Paris, France.
- Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
- Department of Surgery, Monash University, Melbourne, Australia.
- Department of Urology, La Croix du Sud Hospital, Toulouse, France.
Förderung
- University of Padua
Zitieren
APA
Zattoni, F., Marra, G., Martini, A., Kasivisvanathan, V., Grummet, J., Harkin, T., Ploussard, G., Olivier, J., Chiu, P. K., Valerio, M., Marquis, A., Gontero, P., Guo, H., Zhuang, J., Frydenberg, M., Moon, D., Morlacco, A., Kretschmer, A., Barletta, F., …, & EAU-YAU Prostate Cancer Working Party (2023). Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. European Urology Focus. https://doi.org/10.1016/j.euf.2023.01.016
Vancouver
Zattoni F, Marra G, Martini A, Kasivisvanathan V, Grummet J, Harkin T, et al. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. European Urology Focus. 2023. doi:10.1016/j.euf.2023.01.016
BibTeX
@article{Zattoni2023,
author = {Zattoni, Fabio and Marra, Giancarlo and Martini, Alberto and Kasivisvanathan, Veeru and Grummet, Jeremy and Harkin, Timothy and Ploussard, Guillaume and Olivier, Jonathan and Chiu, Peter K and Valerio, Massimo and Marquis, Alessandro and Gontero, Paolo and Guo, Hongqian and Zhuang, Junlong and Frydenberg, Mark and Moon, Daniel and Morlacco, Alessandro and Kretschmer, Alexander and Barletta, Francesco and Heidegger, Isabel and Tilki, Derya and van den Bergh, Roderick and Dal Moro, Fabrizio and Briganti, Alberto and Montorsi, Francesco and Novara, Giacomo and Gandaglia, Giorgio and EAU-YAU Prostate Cancer Working Party, EAU-YAU Prostate Cancer Working Party},
title = {Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study},
journal = {European Urology Focus},
year = {2023},
doi = {10.1016/j.euf.2023.01.016}
}
EUVIMED